Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

NegEnt Spray: An Original CE Medical Device, Based on Liposomal Cannabidiol and Chamomile Hydrolate, for the Treatment of Muscles and Joints

Version 1 : Received: 10 April 2024 / Approved: 10 April 2024 / Online: 11 April 2024 (09:02:26 CEST)

How to cite: Scrimali, T. NegEnt Spray: An Original CE Medical Device, Based on Liposomal Cannabidiol and Chamomile Hydrolate, for the Treatment of Muscles and Joints. Preprints 2024, 2024040755. https://doi.org/10.20944/preprints202404.0755.v1 Scrimali, T. NegEnt Spray: An Original CE Medical Device, Based on Liposomal Cannabidiol and Chamomile Hydrolate, for the Treatment of Muscles and Joints. Preprints 2024, 2024040755. https://doi.org/10.20944/preprints202404.0755.v1

Abstract

Musculoskeletal disorders are a common occurrence in Europe, affecting millions of people and costing billions of euros in social security services. Traditional treatments using drugs like non-steroidal anti-inflammatory drugs (NSAIDs) can cause gastric damage, making prolonged use difficult. To address this issue, the Author has developed NegEnt Spray - Muscles and Joints, a topical medical device that uses liposomal cannabidiol and chamomile hydrolate to reduce inflammation and pain in musculoskeletal disorders. The liposomal technology used in NegEnt Spray allows for better bioavailability and a more targeted action, while chamomile hydrolate provides a natural anti-inflammatory and soothing effect. The spray is non-greasy, absorbs quickly, and can be used under any circumstances. Its pocket-sized design makes it easy to carry and use throughout the day. With NegEnt Spray, patients can alleviate discomfort and pain associated with musculoskeletal disorders without worrying about the side effects of traditional treatments.

Keywords

 Musculoskeletal disorders, Cannabidiol, Liposomal technology, Chamomile hydrolate, Topical treatment.

Subject

Medicine and Pharmacology, Pharmacy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.